Welcome to our dedicated page for Delphx Cap Mkts news (Ticker: DPXCF), a resource for investors and traders seeking the latest updates and insights on Delphx Cap Mkts stock.
DelphX Capital Markets Inc. (OTCQB: DPXCF) generates news that reflects its focus on structured products at the intersection of fixed-income and cryptocurrency markets. The company’s disclosures highlight product development, capital-raising transactions, and initiatives related to its Quantem Crypto Securities (QCS) program.
Recent announcements have emphasized non-brokered private placements of units composed of common shares and warrants, with proceeds intended for working capital, corporate overhead, or general corporate purposes. These updates often include details on warrant terms, related party participation, and the need for TSX Venture Exchange approval, offering insight into how DelphX funds its activities and manages its capital structure.
Another key theme in DelphX news is the evolution of its QCS hedging solution. The company has reported marketing efforts to digital-asset treasuries and institutional participants, interest from a U.S. primary dealer evaluating a proof-of-concept deployment, and due diligence by multiple crypto-asset treasuries. It has also announced a non-binding letter of intent with Belgravia Hartford Capital Inc. for a potential first commercial QCS transaction aimed at protecting corporate Bitcoin treasury holdings.
Corporate governance and compensation developments also appear in DelphX news, including stock option grants under its option plan and transitions in the Chief Financial Officer role. For investors and observers, the DPXCF news stream offers ongoing context on product commercialization efforts, financing activities, and the company’s positioning within structured credit and digital-asset hedging.
Users following DelphX news can review these recurring topics to monitor how the company advances its proprietary CPO, CRN, and QCS offerings, and how regulatory approvals, market conditions, and institutional engagement influence its trajectory.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) has announced significant achievements in 2024 and outlined its growth strategy for 2025. The company is preparing to execute its first commercial transactions in Q1 2025, involving downgrade protection coverage on a $3 billion notional value bond portfolio.
The company's Credit Rating Securities (CRS) program has received positive feedback from hedge funds and institutional buyers, with active term sheets already exchanged between parties. This innovative platform enables insurance companies, hedge funds, and institutional investors to manage downgrade risks while generating new returns.
CEO Patrick Wood emphasized that DelphX is delivering the most significant innovation in fixed income markets in over a decade, with the company positioned for increased CRS adoption and positive cash flows in 2025.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) has completed its previously announced non-brokered private placement, raising C$348,100 through the issuance of 2,900,834 units at C$0.12 per unit. Each unit includes one common share and one purchase warrant, exercisable at C$0.20 for five years.
Insiders participated by subscribing for 420,000 units. AlphaNorth Asset Management will receive C$3,528 in finder's fees and 29,400 finders' warrants. The offering, conditionally accepted by TSX Venture Exchange, includes a four-month plus one day hold period for issued securities. Proceeds will be used for general corporate purposes.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announces the issuance of 428,571 common shares at a deemed price of C$0.14 per share to a consultant. The shares, valued at C$60,000, are being issued as payment for services related to the Company's Credit Rating Security (CRS) product, including refinement of pricing models, preparation of presentations, and assistance with broker dealer negotiations. Following the issuance, which requires TSX Venture Exchange approval, DelphX will have 182,102,033 common shares outstanding.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announced it will issue 138,888 common shares to a consultant as payment for services related to securing a non-binding letter of intent with hedge funds for up to $3 billion of notional credit spread protection through their CRS program. The shares will be issued at $0.18 per share, totaling C$25,000. Following the issuance, which requires TSX Venture Exchange approval, DelphX will have 181,812,350 common shares outstanding. The shares will be issued as restricted securities under U.S. Securities Act exemptions.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announces a non-brokered private placement to raise C$348,100 through the issuance of 2,900,833 units at C$0.12 per unit. Each unit includes one common share and one purchase warrant exercisable at C$0.20 for five years. The company will pay cash finder's fees and issue finders' warrants to eligible finders. The offering requires TSX Venture Exchange approval and includes a four-month plus one-day hold period. Proceeds will be used for general corporate purposes.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announces plans to seek TSX Venture Exchange approval to extend the exercise period of 5,422,221 share purchase warrants by one year to December 7, 2025. The warrants, originally issued in a December 2022 private placement, are exercisable at $0.15 per common share. Of these warrants, 1,611,111 are held by related parties, constituting a related party transaction. The transaction is exempt from formal valuation and minority approval requirements as the warrants' fair market value is below 25% of DelphX's market capitalization.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), a leader in developing new structured products for the fixed income market, has announced the grant of 1,650,000 stock options to eligible participants under its stock option plan. The Board of Directors approved this grant with the following terms:
- Two-year maturity
- Exercise price of $0.25 per common share
- Options are exercisable for common shares of DelphX
This decision aligns with the company's stock option plan and may be seen as a strategy to incentivize and retain key personnel or partners.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) has announced a non-binding letter of intent with multiple hedge funds to offer up to $3 billion of notional credit spread protection through its Credit Rating Securities (CRS) program. The agreement, dated August 27, 2024, is subject to conditions including DelphX facilitating bond portfolios for credit spread protection and final tax review. The company reports positive interest from potential buyers of protection, as CRS offers a new risk management tool for insurance companies and others seeking downgrade risk mitigation. DelphX will continue to update on the CRS program's progress.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), a leader in developing new structured products for the fixed income market, has announced the grant of 1,200,000 stock options to eligible participants. The options, approved by the company's Board of Directors, have a two-year maturity and can be exercised at $0.25 per common share. This grant is part of DelphX's stock option plan and aims to align the interests of participants with those of shareholders, potentially incentivizing performance and retention.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) has successfully closed its over-subscribed non-brokered private placement, raising C$539,000 by issuing 4,491,666 units at C$0.12 per unit. Each unit comprises one common share and one warrant, with warrants exercisable at C$0.25 for five years. Insiders participated in the offering, subscribing for 666,666 units. The company will pay cash finder's fees totaling C$37,730 and issue 314,417 finders' warrants to eligible finders. The offering is subject to final TSX Venture Exchange approval, with securities having a four-month plus one-day hold period. DelphX plans to use the net proceeds for general corporate purposes.
FAQ
What is the current stock price of Delphx Cap Mkts (DPXCF)?
What is the market cap of Delphx Cap Mkts (DPXCF)?
